In this study, we found that the induction of PDE4D expression by roflumilast synergized with IFN-α to reduce the cAMP level and potentiated the antiproliferation effect of IFN-α on bladder cancer in both the cell lines and mice xenograft model. This evidence concerns the gene PDE4D and urinary bladder carcinoma.